Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Talbert

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Pharmacotherapy|October 23, 2002
Modification of high-density lipoprotein cholesterol in the management of cardiovascular riskJim Koeller, Robert L Talbert
Pharmacotherapy|January 17, 2002
A review of vasopeptidase inhibitors: a new modality in the treatment of hypertension and chronic heart failureSurakit Nathisuwan, Robert L Talbert
Journal of Cardiovascular Pharmacology and Therapeutics|August 17, 2004
Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trialJerry L Bauman, Robert L Talbert
Expert Opinion on Drug Safety|April 10, 2010
Proton pump inhibitors and clopidogrel: is it a significant drug interaction?Ola O Oyetayo, Robert L Talbert
Pharmacotherapy|July 12, 2005
Aspirin resistance: an evaluation of current evidence and measurement methodsChristopher P Martin, Robert L Talbert
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2015
Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadismHayley Gray, Jennifer Seltzer, Robert L Talbert
The Journal of Urology|April 12, 2005
Re: transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albugineaRobert L Talbert, W Jerry Easterling, William Fitch
Pharmacotherapy|June 29, 2006
Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reductionMatthew K Ito, Robert L Talbert, Sotirios Tsimikas
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Niacin and the National Cholesterol Education Program Adult Treatment Panel III Guidelines: case studiesRobert L Talbert, John A Pieper, Matthew K Ito, et al.
Journal of Managed Care Pharmacy : JMCP|November 7, 2009
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care settingMark J Cziraky, Karol E Watson, Robert L Talbert
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Pharmacotherapy|October 23, 2002
Modification of high-density lipoprotein cholesterol in the management of cardiovascular riskJim Koeller, Robert L Talbert
Pharmacotherapy|January 17, 2002
A review of vasopeptidase inhibitors: a new modality in the treatment of hypertension and chronic heart failureSurakit Nathisuwan, Robert L Talbert
Journal of Cardiovascular Pharmacology and Therapeutics|August 17, 2004
Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trialJerry L Bauman, Robert L Talbert
Expert Opinion on Drug Safety|April 10, 2010
Proton pump inhibitors and clopidogrel: is it a significant drug interaction?Ola O Oyetayo, Robert L Talbert
Pharmacotherapy|July 12, 2005
Aspirin resistance: an evaluation of current evidence and measurement methodsChristopher P Martin, Robert L Talbert
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2015
Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadismHayley Gray, Jennifer Seltzer, Robert L Talbert
The Journal of Urology|April 12, 2005
Re: transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albugineaRobert L Talbert, W Jerry Easterling, William Fitch
Pharmacotherapy|June 29, 2006
Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reductionMatthew K Ito, Robert L Talbert, Sotirios Tsimikas
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Niacin and the National Cholesterol Education Program Adult Treatment Panel III Guidelines: case studiesRobert L Talbert, John A Pieper, Matthew K Ito, et al.
Journal of Managed Care Pharmacy : JMCP|November 7, 2009
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care settingMark J Cziraky, Karol E Watson, Robert L Talbert
Pageof 6